Severe clinical manifestation of mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase deficiency associated with two novel mutations: a case report
Open Access
- 9 October 2019
- journal article
- case report
- Published by Springer Nature in BMC Pediatrics
- Vol. 19 (1) , 1-6
Abstract
Background: Mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase (mHS) deficiency is an autosomal recessive inborn error of metabolism, which will give rise to failure of ketogenesis in liver during illness or fasting. It is a very rare disease with only a few patients reported worldwide, most of which had a good prognosis after proper therapies. Case presentation: We report a 9-month-old boy with mHS deficiency presenting with unusually severe and persistent acidosis after diarrhea and reduced oral food intake. The metabolic acidosis persisted even after supplementation with sugar and alkaline solution. Blood purification and assisted respiration alleviated symptoms, but a second onset induced by respiratory infection several days later led to multiple organ failure and death. Urine organic acid analysis during the acute episode revealed a complex pattern of ketogenic dicarboxylic and 3-hydroxydicarboxylic aciduria with prominent elevation of glutaric acid and adipic acid, which seem to be specific to mHS deficiency. Plasma acylcarnitine analysis revealed elevated 3-hydroxybutyrylcarnitine and acetylcarnitine. This is the first report of elevated 3-hydroxybutyrylcarnitine in mHS deficiency. Whole exome sequencing revealed a novel compound heterozygous mutation in HMGCS2 (c.100C > T and c.1465delA). Conclusion: This severe case suggests the need for patients with mHS deficiency to avoid recurrent illness because it can induce severe metabolic crisis, possibly leading to death. Such patients may also require special treatment, such as blood purification. Urine organic acid profile during the acute episode may give a hint to the disease.Keywords
This publication has 19 references indexed in Scilit:
- Mitochondrial 3‐hydroxy‐3‐methylglutaryl‐CoA synthase deficiency: urinary organic acid profiles and expanded spectrum of mutationsJournal of Inherited Metabolic Disease, 2014
- New case of mitochondrial HMG-CoA synthase deficiency. Functional analysis of eight mutationsEuropean Journal of Medical Genetics, 2013
- 3-Hydroxyacyl-Coenzyme A Dehydrogenase Deficiency and Hyperinsulinemic Hypoglycemia: Characterization of a Novel Mutation and Severe Dietary Protein SensitivityThe Journal of Clinical Endocrinology & Metabolism, 2009
- Refining the diagnosis of mitochondrial HMG‐CoA synthase deficiencyJournal of Inherited Metabolic Disease, 2006
- The diagnosis of mitochondrial HMG-CoA synthase deficiencyThe Journal of Pediatrics, 2002
- Mitochondrial 3-Hydroxy-3-Methylglutaryl-CoA Synthase Deficiency: Clinical Course and Description of Causal Mutations in Two PatientsPediatric Research, 2001
- Hepatic Mitochondrial 3-Hydroxy-3-Methylglutaryl-Coenzyme A Synthase DeficiencyPediatric Research, 1998
- Fasting Hypoketotic Coma in a Child with Deficiency of Mitochondrial 3-Hydroxy-3-Methylglutaryl-CoA SynthaseNew England Journal of Medicine, 1997
- Urinary 3-hydroxydicarboxylic acids in pathophysiology of metabolic disorders with dicarboxylic aciduriaMetabolism, 1991
- Glutaric acidaemia type II (multiple Acyl‐Coa dehydrogenation deficiency)Journal of Inherited Metabolic Disease, 1984